Precision Sells Off Autoimmune Rights For Allogeneic CAR-T To TG Therapeutics

TG and Precision signed a deal for Precision's off-the-shelf CAR-T, both companies having recently made strategic pivots. • Source: Shutterstock

More from Deals

More from Business